11 – 20 of 40
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Dopaminergic Progenitors Derived From Epiblast Stem Cells Function Similarly to Primary VM-Derived Progenitors When Transplanted Into a Parkinson’s Disease Model
(
- Contribution to journal › Article
- 2018
-
Mark
Target-specific forebrain projections and appropriate synaptic inputs of hESC-derived dopamine neurons grafted to the midbrain of parkinsonian rats
(
- Contribution to journal › Article
-
Mark
Parkin absence accelerates microtubule aging in dopaminergic neurons
(
- Contribution to journal › Article
-
Mark
Glutathione S-transferase alpha 4 prevents dopamine neurodegeneration in a rat alpha-synuclein model of Parkinson's disease
(
- Contribution to journal › Article
- 2017
-
Mark
Predictive Markers Guide Differentiation to Improve Graft Outcome in Clinical Translation of hESC-Based Therapy for Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
Allelic difference in Mhc2ta confers altered microglial activation and susceptibility to α-synuclein-induced dopaminergic neurodegeneration
(
- Contribution to journal › Article
-
Mark
The Complex Genetics behind Neurodegeneration and Susceptibility to Parkinson’s disease
2017)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Astrocytic expression of GSTA4 is associated to dopaminergic neuroprotection in a rat 6-OHDA model of Parkinson’s disease
(
- Contribution to journal › Article
-
Mark
Strategies for bringing stem cell-derived dopamine neurons to the clinic : A European approach (STEM-PD)
(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2016
-
Mark
Pathogenic effects of alpha-synuclein: modifications and toxicity
2016)(
- Thesis › Doctoral thesis (compilation)